We've found
13,253
archived clinical trials in
Arthritis
We've found
13,253
archived clinical trials in
Arthritis
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Updated: 4/13/2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
Updated: 4/14/2016
A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Updated: 4/15/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials